S0502 Cycle-Specific Treatment Form S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Source Form: NCI FormBuilder:

  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Gastrointestinal Stromal Tumor NCT00324987 Treatment - S0502 Cycle-Specific Treatment Form - 2320335v1.0

Intergroup Coalition Against Sarcomas (ICAS)

  1. StudyEvent: S0502 Cycle-Specific Treatment Form
    1. Intergroup Coalition Against Sarcomas (ICAS)
Vital Status
Has the patient progressed per the definition of Section 10.0 of the protocol?
Treatment For This Cycle
Were there any dose modifications or additions/omissions to protocol treatment?
Dose modification
Dose Modification Reason
Modification due to Adverse Event

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial